Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-05

Clinical Trial Update: Double-blind Pilot Trial of Mirtazapine for the Treatment of Co-occurring AD/MDD. [Phase 2]

View source ↗

Summary

A double-blind Phase 2 pilot trial evaluated mirtazapine for co-occurring Major Depressive Disorder and Alcohol Use Disorder. The study has completed and result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • mirtazapine (mirtazapine)

Snippet

Sponsor: University of Pittsburgh | Conditions: Major Depressive Disorder, Alcohol Use Disorder | Phase 2 | Status: COMPLETED | Results posted: 2017-05-05